Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects
about
Leukotrienes and aspirin induced asthmaNational Athletic Trainers' Association position statement: management of asthma in athletes.Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs.From bench to bedside. The hurdles of discovering a new leukotriene receptor antagonist.Treatment of aspirin-intolerant asthma with antileukotrienes.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Role of leukotrienes in asthma pathophysiology.Asthma medications: basic pharmacology and use in the athleteSevere asthma: definition and mechanisms.Antileukotrienes in clinical development for asthma.Complete resolution of airway hyperresponsiveness in aspirin-sensitive asthmatic patientsThe potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field.Comprehensive asthma management: guidelines for clinicians.Anti-leukotriene agents: a new direction in asthma therapy.Clinical pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitorsEndothelins-induce cyclicAMP formation in the guinea-pig trachea through an ETA receptor- and cyclooxygenase-dependent mechanism.Inflammation, inflammatory mediators, and mediator antagonists in asthma.Leukotriene receptor antagonists: clinical effects.Leukotrienes as Mediators of Airway Obstruction
P2860
Q24563001-1206B58C-8833-40FE-8B20-2C86123BB4BCQ28769235-04083FAF-09B7-49F6-B1F1-41B587FE0E6EQ33595339-0ECFCBA1-F823-4087-8E76-392FE8D749CDQ33836674-10E50D87-41C6-4189-AE14-0B7B9F28DA7DQ33836771-E8723403-2F46-447C-B485-F8980C3EA143Q33976334-F3E08195-AE8E-46DF-B407-061030E69348Q33988564-702E82F7-730B-47C5-8998-4FA762B515EBQ34246031-8D02BFE4-E08E-4637-B45B-CB6E4CEDADACQ34364866-504910CE-1C85-4F52-81EB-29725C9FFF32Q34481959-9266C531-DABC-4EC4-A71A-D88A28CE88BCQ35938732-C2A39594-A167-4A15-9DAB-8284DD9C9729Q37016080-C2E38DAD-1F9C-40CD-8A7B-733DCD0A592CQ39442838-57F9CFB4-3928-4029-A5F7-AB0EF2844ED5Q41270730-1A997AA4-1EFF-4A72-BBE7-308DF6BE0DE4Q42541810-4C3AC1B2-D564-4DD8-B80C-85D901226E7CQ42703977-6EEF0A3C-10B0-4692-8365-4BE1FB4D7ABBQ45071770-B0C79ED0-40EE-49EF-B038-C2B94754628DQ55686747-EEBDBCC0-E6D4-4B5A-8009-28A2E0EEB65CQ57240752-C0280FB1-50D8-4536-88F7-52D850384D5F
P2860
Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@ast
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@en
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@nl
type
label
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@ast
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@en
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@nl
prefLabel
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@ast
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@en
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@nl
P2093
P2860
P356
P1433
P1476
Effect of the leukotriene rece ...... n sensitive asthmatic subjects
@en
P2093
D J Margolskee
O Zetterström
S E Dahlén
P2860
P304
P356
10.1136/THX.48.12.1205
P407
P577
1993-12-01T00:00:00Z